 |
|
Diminazene aceturate exacerbates renal fibrosis after unilateral ureteral obstruction in female mice
Yosep Kim, Jongwan Kim, Sang Jun Han
Kidney Res Clin Pract. 2023;42(2):188-201. Published online 2023 Mar 22 DOI: https://doi.org/10.23876/j.krcp.22.033
|
|
Citations to this article as recorded by
 Targeting renal damage: The ACE2/Ang-(1–7)/mas axis in chronic kidney disease
Jian Zheng, Hua Hao
Cellular Signalling.2024; 124: 111413. CrossRef Pharmacokinetics and safety of pirfenidone in individuals with chronic kidney disease (CKD) stage G2 and G3a: A single-dose, Phase I, bridging study
Dianwen Yu, Rui Zhang, Jinping Zhou, Pengpeng Guo, Peixia Li, Menghan Ye, Yani Liu, Shaojun Shi
Journal of Pharmaceutical Sciences.2024;[Epub] CrossRef Nephroprotective effects of diminazene on doxorubicin-induced acute kidney injury in rats
Yousuf Al Suleimani, Raya Al Maskari, Badreldin H. Ali, Haytham Ali, Priyadarsini Manoj, Ali Al-Khamiyasi, Aly M. Abdelrahman
Toxicology Reports.2023; 11: 460. CrossRef
|